Clinical Trial Update: HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating HLA-nonidentical stem cell and natural killer cell transplantation in children under two with hematologic malignancies; results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Histiocytosis
• Lymphocytic Leukemia
• Myelodysplasia

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Acute Myeloid Leukemia, Acute Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2015-12-14